Author： Hartshorne Geraldine M
Publisher： Reproductive Healthcare Ltd
ISSN： 1472-6483
Source： Reproductive BioMedicine Online, Vol.11, Iss.4, 2005-10, pp. : 404-407
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Assisted conception is among many tissue-processing disciplines encompassed by new European legislation on the quality and safety of tissues and cells used therapeutically. These directives have highlighted interdisciplinary differences in some current practices, such as variations in laboratory air quality. This commentary discusses the likely requirements of the EU directives for air quality in tissue-processing laboratories. It also draws attention to the concept of validation. Validation becomes essential to justify all processes, and would be an essential tool to support any deviations from normal 'Good Manufacturing Practices', such as adopting a lesser grade of laboratory air quality.
Related content
Access to resources
Recommend
EU Directive on clinical trials may be problematic
Inpharma, Vol. 1, Iss. 1339, 2002-01 ,pp. :
The future of noncommercial research in EU member states is threatened by a new EU directive
Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. :
EU healthcare directive a new frontier for the UK?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 558, 2008-01 ,pp. :